Acrolein inhibits respiration in isolated brain mitochondria

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1535, Issue 2, 2001, Pages 145-152

  Picklo, Matthew J ^a   Montine, Thomas J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acrolein; Alzheimer's disease; Lipid peroxidation; Mitochondria; Neurodegeneration; Respiration

Indexed keywords

ACETYLCYSTEINE; ACROLEIN; CALCIUM; CYTOCHROME C; CYTOCHROME C OXIDASE; GLUTATHIONE; LIPID; M PROTEIN; MITOCHONDRIAL ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN MITOCHONDRION; CALCIUM TRANSPORT; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME RELEASE; IC 50; LIPID PEROXIDATION; MALE; METABOLIC INHIBITION; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ACROLEIN; ANIMALS; BRAIN; CALCIUM; CYTOCHROME C GROUP; LIPID PEROXIDATION; MALE; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035857493     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(00)00093-4     Document Type: Article

References (47)

1. Prevention of post-ischemic brain lipid conjugated diene production and neurological injury by hydroxyethyl starch-conjugated deferoxamine
2. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients
3. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease
4. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
5. Reactions of 4-hydroxy-2(E)-nonenal and related aldehydes with proteins studied by carbon-13 nuclear magnetic resonance spectroscopy
6. Covalent modifications of aminophospholipids by 4-hydroxynonenal
7. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde, and related aldehydes
8. Pyrrole formation from 4-hydroxynonenal and primary amines
9. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease
10. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype
11. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4
12. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease
13. Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease
14. Gas chromatographic analysis of reactive carbonyl compounds formed from lipids upon UV-irradiation
15. Biological Interactions of α,β-unsaturated aldehydes
16. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
17. Mitochondria in neurodegeneration: Acute ischemia and chronic neurodegenerative disease
18. Cardiac reperfusion injury: Aging, lipid peroxidation, and mitochondrial dysfunction
19. Colocalization of Bcl-2 and 4-hydroxynonenal modified proteins in microglial cells and neurons of rat brain following transient focal ischemia
20. The cellular production of hydrogen peroxide
21. Superoxide production by the mitochondrial respiratory chain
22. Lipid composition in synaptic and non-synaptic mitochondria from rat brains and effect of aging
23. Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: Immunochemical detection in mitochondria exposed to oxidative stress
24. Cerebral ischemia and reperfusion: Prevention of brain mitochondrial injury by lidoflazine
25. 4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites
26. Removal and binding of polar lipids in mitochondria and other membrane systems
27. Microdetermination of phosphorous
28. Cytochrome c release from brain mitochondria is independent of the mitochondrial permeability transition
29. High-pressure liquid chromatography quantitation of cytochrome c using 393 nm detection
30. Determination of acrolein in urine by liquid chromatography and fluorescence detection of its quinoline derivative
31. Quantitative determination of the lipid peroxidation product 4-hydroxynonenal by high-performance liquid chromatography
32. Free-SH variations during ATP synthesis by oxidative phosphorylation in heart muscle mitochondria
33. Inhibition of some mitochondrial functions by acrolein and methylvinylketone
34. Inhibition of rat heart mitochondrial electron transport in vitro: Implications for the cardiotoxic action of allylamine, or its primary metabolite, acrolein
35. Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal
36. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition
37. Mitochondrial permeability transition in the central nervous system: Induction by calcium cycling-dependent and -independent pathways
38. Differential Inhibition of phosphate efflux and influx and a possible discrimination between an inner and outer location of the phosphate carrier in mitochondria
39. The transport of inorganic phosphate by the mitochondrial dicarboxylate carrier
40. The inhibition of phosphate entry into rat liver mitochondria by organic mercurials and formaldehyde
41. +: Implications for neurodegeneration
42. Mitochondrial free radical production and oxidative pathophysiology: Implications for neurodegenerative disease
43. Mechanisms by which mitochondria transport calcium
44. Mitochondrial depolarization is not required for neuronal apoptosis
45. Release of cytochrome c from mitochondria to cytosol in gerbil hippocampal CA1 neurons after transient forebrain ischemia
46. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization
47. Energy requirements of brain function: When is energy limiting?